Recently, studies have highlighted that an immunoscore combining the density of CD8+, FoxP3+, and CD68+ cells within stromal and intra-tumoral compartments serves as a significant prognostic marker in HNSCC (60–62). The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.